Intriguingly, upon downregulating the expression of SEC61A1 in AML cell lines (Figures S1a, b and S2), we observed a simultaneous reduction in FLT3 expression (Figure S1a and b). This evidence concerns the gene FLT3 and acute myeloid leukemia.